Mohammad Husain
Overview
Explore the profile of Mohammad Husain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1067
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Irshad R, Batool F, Raj N, Karim S, Alkreathy H, Manzoor N, et al.
Toxicol Appl Pharmacol
. 2024 May;
487:116978.
PMID: 38795847
Non-small cell lung cancer (NSCLC) is a complex malignancy with a high degree of heterogeneity, representing approximately 85% of all lung cancer cases. The treatment landscape for NSCLC has been...
2.
Sharma D, Singh A, Wilson C, Swaroop P, Kumar S, Yadav D, et al.
Pediatr Surg Int
. 2024 Feb;
40(1):57.
PMID: 38353772
Purpose: Wilms' tumor (WT) is a rare kidney cancer that primarily affects children. Exosomes are extracellular vesicles that cargo nucleic acids, proteins,etc. for cellular communication. Long non-coding RNAs (lncRNAs) have...
3.
Bhat A, Padder R, Husain M, Patel R
Mol Pharm
. 2024 Jan;
21(2):535-549.
PMID: 38271213
We report an efficient sustainable two-step anion exchange synthetic procedure for the preparation of choline API ionic liquids (Cho-API-ILs) that contain active pharmaceutical ingredients (APIs) as anions combined with choline-based...
4.
Nabi S, Ramzan F, Lone M, Nainwal L, Hamid A, Batool F, et al.
J Biomol Struct Dyn
. 2023 Jul;
42(14):7610-7627.
PMID: 37517055
A series of halogen-substituted aurone derivatives were synthesized and evaluated for an anti-proliferative study against NCI 60 cancer cell line panel and showed that most of the compounds predominantly exhibited...
5.
Irshad R, Tabassum S, Husain M
Curr Top Med Chem
. 2023 May;
23(12):1090-1103.
PMID: 37218199
It is now an undisputed fact that cancer cells undergo metabolic reprogramming to support their malignant phenotype, and it is one of the crucial hallmarks which enables cancer cells to...
6.
Gupta P, Rai A, Hans C, Husain M
Curr HIV Res
. 2023 Feb;
21(2):99-108.
PMID: 36809950
Background: The genetic diversity in HIV-1 genes affects viral pathogenesis in HIV-1 positive patients. Accessory genes of HIV-1, including , are reported to play a critical role in HIV pathogenesis...
7.
Irshad R, Raj N, Gabr G, Manzoor N, Husain M
Front Pharmacol
. 2022 Oct;
13:1018974.
PMID: 36313358
Non-small cell lung cancer (NSCLC) is one of the most malignant types of cancer with soaring incidence rates worldwide, attributed to its heterogeneity and complex etiology. Evidently, alternative anti-cancer therapies...
8.
Khan N, Khan P, Inam A, Ahmad K, Yousuf M, Islam A, et al.
RSC Adv
. 2022 May;
10(34):20129-20137.
PMID: 35520423
Microtubule affinity regulating kinase 4 (MARK4) is a Ser/Thr kinase, considered as a potential drug target for cancer, diabetes and neurodegenerative diseases. Due to its significant role in the development...
9.
Ali R, Tabrez S, Akand S, Rahman F, Husein A, Arish M, et al.
Front Cell Infect Microbiol
. 2021 Nov;
11:749420.
PMID: 34778106
Background: Visceral leishmaniasis (VL), caused by the protozoan parasite (), is the most severe form of leishmaniasis. It is largely responsible for significant morbidity and mortality in tropical and subtropical...
10.
Alam S, Mohammad T, Padder R, Hassan M, Husain M
J Cell Biochem
. 2021 Oct;
123(2):259-274.
PMID: 34636440
The treatments available for non-small cell lung cancer exert various side effects in patients, and the burden of treatment cost is high. Therefore, exploring the alternative system of medicines, including...